VCAM1 and nonpapillary renal cell carcinoma: Based on the log-rank test in GEPIA, high mRNA expression of VCAM1 (p = 0.041) was significantly associated with a better prognosis in ccRCC patients, as shown for overall survival (Figure 10B).